Detalles de la búsqueda
1.
Disrupting prostate cancer research: Challenge accepted; report from the 2023 Coffey-Holden Prostate Cancer Academy Meeting.
Prostate;
2024 Apr 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38682886
2.
Association of PARP inhibitor treatment on the prevalence and progression of clonal hematopoiesis in patients with advanced prostate cancer.
Prostate;
84(10): 954-958, 2024 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-38641986
3.
Efficacy of systemic therapies in men with metastatic castration resistant prostate cancer harboring germline ATM versus BRCA2 mutations.
Prostate;
81(16): 1382-1389, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34516663
4.
Fitness and prostate cancer screening, incidence, and mortality: Results from the Henry Ford Exercise Testing (FIT) Project.
Cancer;
127(11): 1864-1870, 2021 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33561293
5.
Reversing the effects of androgen-deprivation therapy in men with metastatic castration-resistant prostate cancer.
BJU Int;
128(3): 366-373, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-33765326
6.
Therapeutic targeting of the DNA damage response in prostate cancer.
Curr Opin Oncol;
32(3): 216-222, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32168038
7.
A multidisciplinary approach to address unmet needs in the management of patients with non-metastatic castration-resistant prostate cancer.
Prostate Cancer Prostatic Dis;
2024 Mar 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38431761
8.
Bipolar androgen therapy plus nivolumab for patients with metastatic castration-resistant prostate cancer: the COMBAT phase II trial.
Nat Commun;
15(1): 14, 2024 01 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38167882
9.
Advancing the care of individuals with cancer through innovation & technology: Proceedings from the cardiology oncology innovation summit 2020 and 2021.
Am Heart J Plus;
38: 100354, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38510746
10.
Acting on Actionable Mutations in Metastatic Prostate Cancer.
J Clin Oncol;
41(18): 3295-3299, 2023 06 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-37098244
11.
Phase II Randomized Study of Salvage Radiation Therapy Plus Enzalutamide or Placebo for High-Risk Prostate-Specific Antigen Recurrent Prostate Cancer After Radical Prostatectomy: The SALV-ENZA Trial.
J Clin Oncol;
41(6): 1307-1317, 2023 02 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-36367998
12.
Co-occurring BRCA2/SPOP Mutations Predict Exceptional Poly (ADP-ribose) Polymerase Inhibitor Sensitivity in Metastatic Castration-Resistant Prostate Cancer.
Eur Urol Oncol;
2023 Dec 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-38072760
13.
Clonal Hematopoiesis of Indeterminate Potential in Patients with Solid Tumor Malignancies.
Cancer Res;
82(22): 4107-4113, 2022 11 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-36040522
14.
Bridging the gap to advance the care of individuals with cancer: collaboration and partnership in the Cardiology Oncology Innovation Network (COIN).
Cardiooncology;
8(1): 2, 2022 Feb 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35139920
15.
Making National Cancer Institute-Designated Comprehensive Cancer Center Knowledge Accessible to Community Oncologists via an Online Tumor Board: Longitudinal Observational Study.
JMIR Cancer;
8(2): e33859, 2022 05 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-35588361
16.
PROMISE: a real-world clinical-genomic database to address knowledge gaps in prostate cancer.
Prostate Cancer Prostatic Dis;
25(3): 388-396, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34363009
17.
A Multicohort Open-label Phase II Trial of Bipolar Androgen Therapy in Men with Metastatic Castration-resistant Prostate Cancer (RESTORE): A Comparison of Post-abiraterone Versus Post-enzalutamide Cohorts.
Eur Urol;
79(5): 692-699, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32624280
18.
Randomized Phase II Trial of Sipuleucel-T with or without Radium-223 in Men with Bone-metastatic Castration-resistant Prostate Cancer.
Clin Cancer Res;
27(6): 1623-1630, 2021 03 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33451978
19.
Differential Activity of PARP Inhibitors in BRCA1- Versus BRCA2-Altered Metastatic Castration-Resistant Prostate Cancer.
JCO Precis Oncol;
52021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34778690
20.
Association between coronary artery calcium and cardiovascular disease as a supporting cause in cancer: The CAC consortium.
Am J Prev Cardiol;
4: 100119, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34327479